Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3
Mengdie Hu, Xiuting Huang, Xueyao Han, Linong Ji Department of Endocrinology and Metabolism, Peking University People’s Hospital, Peking University Diabetes Center, Beijing 100044, People’s Republic of ChinaCorrespondence: Linong Ji; Xueyao HanDepartment of Endocrinology and Meta...
Guardado en:
Autores principales: | Hu M, Huang X, Han X, Ji L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e7967f6353947c7be305f5252029ce0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel insights into genetics and clinics of the HNF1A-MODY
por: Valkovicova Terezia, et al.
Publicado: (2019) -
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
por: Aamir Salam Teeli, et al.
Publicado: (2021) -
MODY3 in the child with type 2 diabetes mellitus phenotype: case report
por: Tamara Leonidovna Kuraeva, et al.
Publicado: (2013) -
Viral Determinants of miR-122-Independent Hepatitis C Virus Replication
por: Sharon E. Hopcraft, et al.
Publicado: (2016) -
Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer
por: Chen J, et al.
Publicado: (2021)